SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-21-000120
Filing Date
2021-08-09
Accepted
2021-08-09 16:48:47
Documents
86
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20210630.htm   iXBRL 10-Q 1817045
2 EX-31.1 a2021q2bhvn10-qexhibit311.htm EX-31.1 10721
3 EX-31.2 a2021q2bhvn10-qexhibit312.htm EX-31.2 10935
4 EX-32.1 a2021q2bhvn10-qexhibit321.htm EX-32.1 7755
  Complete submission text file 0001689813-21-000120.txt   9871774

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20210630.xsd EX-101.SCH 83050
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20210630_cal.xml EX-101.CAL 84036
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20210630_def.xml EX-101.DEF 438855
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20210630_lab.xml EX-101.LAB 846934
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20210630_pre.xml EX-101.PRE 623996
10 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20210630_htm.xml XML 1741177
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 211157181
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences